Latest "Precision Kiosk Technologies" News Stories

05:11 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Precision Kiosk Technologies" found in our extensive news archives from over 250 global news sources.

More Information about Precision Kiosk Technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Precision Kiosk Technologies for you to read. Along with our medical data and news we also list Precision Kiosk Technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Precision Kiosk Technologies Companies for you to search.

Showing "Precision Kiosk Technologies" News Articles 1–25 of 7,100+

Wednesday 19th September 2018

DermTech Announces Enrollment Completion of Clinical Study to Assess DNA Damage and Reversal

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has completed enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of topical agents T4 endonuclease and photolyase to reduce DNA damage induced as measured through gene expression analysis. The study is being co...

Digital China Health to Promote Genomics Diagnostic Support System in China

Digital China Health Technologies will team up with Congenica, a UK company, to market Congenica's Sapientia™, a diagnostic decision support platform for genomics, to China hospitals. Congenica will develop a China-specific version of Sapientia, which will make the advances of genomics and personalized medicine available to clinicians. The company says its platform is particularly useful for...

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company

Abzena, plc (AIM: ABZA, Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed an antibody humanisation agreement with Tmunity Therapeutics (Tmunity), a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen Receptor T...

Siemens Mobility Puts Stratasys Additive Manufacturing at the Heart of First Digital Rail Maintenance Center

Ability to rapidly and cost-effectively 3D print replacement parts and production tools on-demand eliminates obsolete parts and warehousing costs Manufacturing time per part reduced by up to 95% Video: Learn more about the use of 3D printing at the Siemens Mobility RRX Rail Service Center

Helix BioPharma Corp HBP Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryHelix BioPharma Corp Helix is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anticancer therapeutic platform has yielded two new drug product candidates, VDOS47 and LDOS47. VDOS47 uses the c...

Palliative care consultation linked to lower deaths by failed code resuscitation

1. Among deaths at one, large children’s hospital, the most common mode of inpatient death was withdrawal of life sustaining technologies, followed by nonescalation of care during or at the time of death, and failed resuscitation (code). 2. Older children, neonates, and children with malignancies were significantly more likely to receive palliative care consultations. For […]

Tuesday 18th September 2018

First laboratory-grown human-skin test service, to use artifical intelligence, to provide clinical trial standard verification for cosmetic, personal hygiene and skin care products

Labskin (Innovenn Ltd.), a wholly owned subsidiary of Integumen plc., (AIM:SKIN) today announces that it has entered into a partnership with RinoLab ( to provide Labskin clients with access to an AI machine learning platform which accelerates development of cosmetics, skincare, woundcare, personal hygiene and pharmaceutical topical drug delivery products. The service is expected to...

3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging combined with the safety and ablation … Continue reading → Cet article 3-Year Clinical Outcomes and BPH Subgroup Analysis o...

Free Telehealth Visits for People Impacted by Hurricane Florence

Residents of North Carolina and South Carolina Displaced by the Storm Can Call National Telehealth Provider MeMD, Toll-Free, to Receive Medical Care for Non-Life-Threatening Illnesses and Injuries In an effort to provide assistance and relief to individuals and families displaced by Hurricane Florence, national telehealth provider MeMD is offering free...

Twist Bioscience Responds to Agilent’s Latest Specious Claims

Twist Bioscience issued the following statement: Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its complaint, Twist informed ...

Continuum Clinical Names Kevin Hartbarger as New VP, Media

Global patient recruitment and retention company, Continuum Clinical is proud to announce Kevin Hartbarger as its new vice president of media. This press release features multimedia. View the full release here:

Foresight Institute Awards Distinguished Student Prize to Carnegie Mellon’s Qi Li.

Foresight Institute, a leading think tank, research, and public interest organization focused on molecular manufacturing and other transformative technologies, announced the 2018 winner for the prestigious Distinguished Student Prize. PALO ALTO, Calif. (PRWEB) September 18, 2018 Foresight Institute, a leading think tank, research, and public interest organization focused on molecular manufacturin...

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and NovellusDx, a leader in functional genomics, today announced the signing of a definitive agreement under which NovellusDx will merge with a newly formed Israeli subsidiary of Cancer Genetics and shareholders of NovellusDx will receive stock ...

INTERPHEX Live!: New Technologies to Help Older Facilities in Aseptic Processing—RABS Retrofits and H2O2 Decon Strategies

VideosLes Edwards, VP of Technology and Business Development at SKAN US, Inc., discusses various issues and solutions surrounding older aseptic system upgrades.

NorthStar Names Merrick CEO, Appoints Hendricks as Board Chair

NorthStar Medical Technologies, which is seeking to become the first U.S. company in decades to domestically produce a widely used medical radioisotope, said it has appointed Stephen Merrick as CEO. Merrick joined Beloit, WI-based NorthStar in 2016 as the company’s chief operating officer and was later given the title of president, which he’ll continue to […]

Expedeon AG comments on recent share price development (news with additional features)

DGAP-News: Expedeon AG / Key word(s): Miscellaneous 18.09.2018 / 15:46 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 18 September 2018 / Expedeon AG comments on recent share price development Heidelberg, Germany and Cambridge, UK, 18 September 2018 - Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard), said today that the management...

Science has helped advance our understanding of #severeasthma, but it may remain uncontrolled. We're committed to redefining how severe #asthma is managed. To achieve this, we've embarked on a program called PRECISION. Dr. Lykke shares more: http://bit.l

Science has helped advance our understanding of #severeasthma, but it may remain uncontrolled. We're committed to redefining how severe #asthma is managed. To achieve this, we've embarked on a program called PRECISION. Dr. Lykke shares more: . #ERSCongress

National Integrated Health Associates Welcomes Sherif Hassan, MD, to the Functional Medicine Team

National Integrated Health Associates (NIHA), a leading integrative medical and dental center in Washington, D.C., is pleased to announce Dr. Sherif Hassan has joined the medical team. WASHINGTON (PRWEB) September 18, 2018 Dr. Sherif Hassan is an internal medicine physician with broad international experience. Trained in the United Kingdom as a Critical Care Physician, he has worked in several Un...

Quanterix CEO Leads Webinar on How Digital Biomarkers are Empowering Drug Development

Top researchers join the discussion on biomarker innovations for accelerating drug development Brief Quanterix business update to be provided as well Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced Chairman and Chief Executive Office...

Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies

Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that they have entered into a collaboration on multiple undisclosed targets. The collabora...

Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman

Hannover, Germany, September 18, 2018 / B3C newswire / -- Implandata Ophthalmic Products GmbH is pleased to announce that Dominick Arena is appointed as its Chairman of the Board effective immediately. Dominick is currently an Executive Advisor for Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry. He brings more than 30 years experience in the ...

TriMedx to buy Aramark healthcare division, including imaging tech services, for $300M

On Monday, Sept. 17, Indianapolis-based TriMedx announced plans to buy the healthcare technologies division of Aramark Corporation for $300 million. The two companies have signed a definitive agreement and expect the transaction to be completed by the end of the year.

Everest Group Recognizes Virtusa as a Major Contender in its PEAK Matrix™ for Digital Services in Life Sciences

Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for its clients, today announced that it has been named a Major Contender in Everest Group’s 2018 PEAK MatrixTM for Digital Services in Life Sciences. Virtusa’s market impact was assessed on t...

Thermal Ablation Effectively Treats Early-stage Lung Cancer

Thermal ablation is a safe, effective treatment for early-stage lung cancer, according to a study published in the journal Radiology. The results show that ablation may be an effective alternative for patients who cannot undergo lung cancer surgery because of age or health status. OAK BROOK, Ill. (PRWEB) September 18, 2018 Thermal ablation is a safe, effective treatment for early-stage lung cance...

V2G Technology: An Energy Game-Changer for All Stakeholders - Once Market Barriers Are Overcome

LONDON, Sept. 18, 2018 /PRNewswire/ -- As the market for EVs begins to take traction, new opportunities are being opened for innovative technologies and approaches Read more...

Quick Search


News Quicklinks